BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 34392977)

  • 1. Para-aortic lymph nodes and ductal adenocarcinoma of the pancreas: Distant neighbors?
    Safi SA; Rehders A; Haeberle L; Fung S; Lehwald N; Esposito I; Ziayee F; Krieg A; Knoefel WT; Fluegen G
    Surgery; 2021 Dec; 170(6):1807-1814. PubMed ID: 34392977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.
    Sperti C; Gruppo M; Blandamura S; Valmasoni M; Pozza G; Passuello N; Beltrame V; Moletta L
    World J Gastroenterol; 2017 Jun; 23(24):4399-4406. PubMed ID: 28706422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Para-aortic lymph node sampling in pancreatic head adenocarcinoma.
    Schwarz L; Lupinacci RM; Svrcek M; Lesurtel M; Bubenheim M; Vuarnesson H; Balladur P; Paye F
    Br J Surg; 2014 Apr; 101(5):530-8. PubMed ID: 24633831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term survival after resection of pancreatic ductal adenocarcinoma with para-aortic lymph node metastasis: case report.
    Masui T; Kubota T; Aoki K; Nakanishi Y; Miyamoto T; Nagata J; Morino K; Fukugaki A; Takamura M; Sugimoto S; Onuma H; Tokuka A
    World J Surg Oncol; 2013 Aug; 11(1):195. PubMed ID: 23945441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of para-aortic lymph node metastasis in pancreatic ductal adenocarcinoma.
    Murakami Y; Uemura K; Sudo T; Hashimoto Y; Yuasa Y; Sueda T
    World J Surg; 2010 Aug; 34(8):1900-7. PubMed ID: 20376442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which patients with para-aortic lymph node (LN16) metastasis will truly benefit from curative pancreaticoduodenectomy for pancreatic head cancer?
    Liu C; Lu Y; Luo G; Cheng H; Guo M; Liu Z; Xu J; Long J; Liu L; Fu D; Ni Q; Li M; Yu X
    Oncotarget; 2016 May; 7(20):29177-86. PubMed ID: 27081079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete circumferential lymphadenectomy around the superior mesenteric artery with preservation of nerve plexus reduces locoregional recurrence after pancreatoduodenectomy for resectable pancreatic ductal adenocarcinoma.
    Hirono S; Kawai M; Okada KI; Miyazawa M; Kitahata Y; Kobayashi R; Hayami S; Ueno M; Yamaue H
    Eur J Surg Oncol; 2021 Oct; 47(10):2586-2594. PubMed ID: 34127329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncological outcome of laparoscopically assisted pancreatoduodenectomy for ductal adenocarcinoma in a retrospective cohort study.
    Kuesters S; Chikhladze S; Makowiec F; Sick O; Fichtner-Feigl S; Hopt UT; Wittel UA
    Int J Surg; 2018 Jul; 55():162-166. PubMed ID: 29807171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group.
    Pedrazzoli S; DiCarlo V; Dionigi R; Mosca F; Pederzoli P; Pasquali C; Klöppel G; Dhaene K; Michelassi F
    Ann Surg; 1998 Oct; 228(4):508-17. PubMed ID: 9790340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended lymphadenectomy in cephalic pancreatoduodenectomy. Personal observations.
    Meriggi F; Gramigna P; Forni E
    Hepatogastroenterology; 2007 Mar; 54(74):549-55. PubMed ID: 17523320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common hepatic artery lymph node metastasis in pancreatic ductal adenocarcinoma: an analysis of actual survival.
    Kuo S; Ventin M; Sato H; Harrison JM; Okuda Y; Qadan M; Ferrone CR; Lillemoe KD; Fernandez-Del Castillo C
    J Gastrointest Surg; 2024 May; 28(5):672-678. PubMed ID: 38704205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
    JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CA19-9 level determines therapeutic modality in pancreatic cancer patients with para-aortic lymph node metastasis.
    Asaoka T; Miyamoto A; Maeda S; Hama N; Tsujie M; Ikeda M; Sekimoto M; Nakamori S
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):75-80. PubMed ID: 29428109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative risk factors for para-aortic lymph node positivity in pancreatic cancer.
    Okada K; Uemura K; Kondo N; Sumiyoshi T; Seo S; Otsuka H; Serikawa M; Ishii Y; Tsuboi T; Murakami Y; Takahashi S
    Pancreatology; 2021 Apr; 21(3):606-612. PubMed ID: 33648880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-center experience of robot-assisted laparoscopic para-aortic lymphadenectomy for staging of locally advanced cervical carcinoma.
    Fastrez M; Goffin F; Vergote I; Vandromme J; Petit P; Leunen K; Degueldre M
    Acta Obstet Gynecol Scand; 2013 Aug; 92(8):895-901. PubMed ID: 23590725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implication of para-aortic lymph node metastasis in resectable pancreatic cancer.
    Doi R; Kami K; Ito D; Fujimoto K; Kawaguchi Y; Wada M; Kogire M; Hosotani R; Imamura M; Uemoto S
    World J Surg; 2007 Jan; 31(1):147-54. PubMed ID: 17171496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of lymph node involvement on long-term survival after R0 pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas.
    Zacharias T; Jaeck D; Oussoultzoglou E; Neuville A; Bachellier P
    J Gastrointest Surg; 2007 Mar; 11(3):350-6. PubMed ID: 17458610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Nomogram for patients undergoing radical Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head.
    Wu C; Hou SZ; Wu Z; Huang X; Wang Z; Tian B
    BMC Cancer; 2021 May; 21(1):624. PubMed ID: 34044806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival advantage with para aortic lymphadenectomy in peri-ampullary cancer: A retrospective cohort study.
    Hafeez Bhatti AB; Dar FS; Sahaab E; Khan NY; Zia H; Rana A; Salih M; Shah NH
    Int J Surg; 2016 Jul; 31():58-62. PubMed ID: 27262530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.
    Riediger H; Keck T; Wellner U; zur Hausen A; Adam U; Hopt UT; Makowiec F
    J Gastrointest Surg; 2009 Jul; 13(7):1337-44. PubMed ID: 19418101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.